Royal Philips

Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Diagnosis and Treatment businesses; Connected Care businesses; Personal Health businesses; and Other. The Diagnosis and Treatment businesses segment consists systems, smart devices, software and services, powered by AI-enabled informatics-that support precision diagnoses and minimally invasive procedures in therapeutic areas such as cardiology, peripheral vascular, neurology, surgery, and oncology. The Connected Care businesses segment consists Hospital Patient Monitoring, Emergency Care, Sleep & Respiratory Care and Connected Care Informatics. The Personal Health businesses segment consists of Oral Healthcare, Personal Care,Mother and Child Care. The Other segment reports on the items Innovation & Strategy, IP Royalties, Central costs, and other small items. The company was founded by Anton Frederik Philips and Gerard Leonard Frederik Philips in 1891 and is headquartered in Amsterdam, the Netherlands.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Diagnosis and Treatment; Connected Care; Personal Health; and Other. The Diagnosis and Treatment segment consists of systems, smart devices, software, and services, powered by AI-enabled solutions that support precision diagnoses and minimally invasive treatment in therapeutic areas such as cardiology, peripheral vascular, neurology, surgery, and oncology. The Connected Care segment focuses on Hospital Patient Monitoring, Sleep and Respiratory Care, and Enterprise Informatics. The Personal Health segment represents Oral Healthcare business unit, Personal Care business unit, and Mother and Child Care business unit. The Other segment is involved on the Innovation and Strategy, IP Royalties, Central costs, and other small items. The company was founded by Anton Frederik Philips and Gerard Leonard Frederik Philips in 1891 and is headquartered in Amsterdam, the Netherlands.

Philips awarded top honor by Red Dot jury with Design Team of the Year award

Philips to repurchase up to 3.2 million shares to cover long-term incentive and employee stock purchase plans

Philips announces positive three-year clinical research results from its Tack Optimized Balloon Angioplasty (TOBA) II below-the-knee (BTK) clinical trial

In this article, we'll take a look at perhaps one of the most well-known conglomerates on Earth, Philips, with the original name Koninklijke Philips N.V. The company has a 100-year history, and has had some issues in the past few decades.

Philips: Upside From A Massive Conglomerate

Philips' Future Health Index 2022 report shows healthcare leaders are rebooting priorities as they emerge from the pandemic

Philips announces exchange ratio for 2021 dividend

Willem Appelo to succeed Sophie Bechu as Philips' Chief Operations Officer

Philips Foundation publishes its 2021 Annual Report

Philips' (PHG) launches innovative new solutions to attract customers amid a global supply crunch and drive top-line growth.

Philips' (PHG) Launches a Range of New Products at EuroPCR 2022

Philips showcases ultra-low contrast PCI solutions at EuroPCR 2022

New release of Philips EchoNavigator helps interventional teams treat structural heart disease with greater ease and efficiency

Philips Annual General Meeting of Shareholders approves dividend and other proposals made to shareholders

Philips shareholders voted against the company's executive compensation plan at the annual shareholders' meeting on Tuesday, ANP reported, in a protest over the company's recent poor results and product recalls.

Philips shareholders vote against executive compensation plan

Philips receives FDA 510(k) clearance for latest breakthrough high-performance MR 7700 system

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION DIRECTLY OR INDIRECTLY TO ANY U.S. PERSON (AS DEFINED IN REGULATION S UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”)) OR ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES OF AMERICA, ITS TERRITORIES AND POSSESSIONS (INCLUDING PUERTO RICO, THE US VIRGIN ISLANDS, GUAM, AMERICAN SAMOA, WAKE ISLAND AND THE NORTHERN MARIANA ISLANDS), ANY STATE OF THE UNITED STATES OR THE DISTRICT OF COLUMBIA OR IN ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS NOTICE.

Koninklijke Philips N.V.: Tender Offers Results Notice

Koninklijke Philips N.V.: Announcement of the indicative Series Acceptance Amounts

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO, OR TO ANY PERSON RESIDENT AND/OR LOCATED IN, ANY JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION IS UNLAWFUL

Koninklijke Philips N.V. Announces Tender Results of Any and All Tender Offer for Certain Outstanding USD-Denominated Notes

Koninklijke Philips N.V. Announces Pricing Terms of Any and All Tender Offer for Certain Outstanding USD-Denominated Notes

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that it has again been recognized on Forbes's America's Best Employers for Diversity 2022 list. Philips' inclusion in this important ranking is a testament to the company's commitment to fostering a diverse and inclusive culture where employees feel valued, safe and supported to be their best. Philips ranked 195 on the 2022 list and is among the top five in the ‘Health

Philips Named to Forbes Best Employers for Diversity 2022 List

Philips at ESOC 2022: showcasing integrated solutions across the stroke care pathway

Philips successfully prices offering of Notes for EUR 2 billion

Philips and Prisma Health sign multi-year, long-term strategic partnership to innovate healthcare across the enterprise and unlock the power of patient data

Koninklijke Philips N.V. Announces Any and All Tender Offer for Certain Outstanding USD-Denominated Notes

Philips launches offering of Green and Sustainability Innovation Notes and a Series of Liability Management Transactions

VIENNA--(BUSINESS WIRE)--Speech Processing Solutions, the global leader in professional speech-to-text solutions sold under the Philips brand, has teamed up with an exciting American start-up named Sembly AI. Together they'll unite to provide high-quality microphones and smart meeting technology. Sembly goes beyond simple speech recognition and offers users instant searchable meeting transcripts, highlights key discussion moments, and creates summaries. Every meeting, perfectly captured The new

Philips Speech Teams Up With Sembly AI to Launch a Brand-new Speech Technology Solution for Meetings

News for Royal Philips Stock (PHG)